| GO | Description | Count | Log10 (q) | Hits |
| ko05418 | Fluid shear stress and atherosclerosis | 29 | −38.94 | AKT1, BCL2, CAV1, CTNNB1, FOS, GSTM1, HMOX1, ICAM1, IFNG, IKBKB, IL1A, IL1B, MMP2, MMP9, NFE2L2, NOS3, PECAM1, PLAT, MAPK8, RELA, CCL2, SELE, THBD, TNF, TNFRSF1A, TP53, VCAM1, VEGFA, NCF1 |
| hsa05200 | Pathways in cancer | 39 | −34.98 | AKT1, AKR1B1, AR, BCL2, CASP3, CASP9, CDKN1A, CTNNB1, EGF, EGFR, ELK1, FOS, GSTM1, HIF1A, HMOX1, IFNG, IGF2, IKBKB, IL4, IL6, CXCL8, MMP1, MMP2, MMP9, MYC, NFE2L2, NOS2, PPARD, PPARG, MAPK1, MAPK8, PTEN, PTGS2, RELA, RXRA, STAT1, TGFB1, TP53, VEGFA |
| hsa04668 | TNF signaling pathway | 22 | −28.78 | AKT1, CASP3, FOS, CXCL2, ICAM1, IKBKB, IL1B, IL6, CXCL10, IRF1, MMP3, MMP9, MAPK1, MAPK8, PTGS2, RELA, CCL2, SELE, TNF, TNFRSF1A, TNFRSF1B, VCAM1 |
| ko05144 | Malaria | 14 | −20.75 | CD40LG, ICAM1, IFNG, IL1B, IL6, CXCL8, IL10, PECAM1, CCL2, SELE, SELP, TGFB1, TNF, VCAM1 |
| ko05140 | Leishmaniasis | 15 | −20.01 | ELK1, FOS, IFNG, IL1A, IL1B, IL4, IL10, NOS2, MAPK1, PTGS2, RELA, STAT1, TGFB1, TNF, NCF1 |
| hsa04066 | HIF-1 signaling pathway | 17 | −20.00 | AKT1, BCL2, CDKN1A, EGF, EGFR, F3, HIF1A, HMOX1, IFNG, IL6, INSR, NOS2, NOS3, SERPINE1, MAPK1, RELA, VEGFA |
| ko04064 | NF-kappa B signaling pathway | 14 | −16.64 | PARP1, BCL2, CD40LG, CXCL2, ICAM1, IKBKB, IL1B, CXCL8, PLAU, PTGS2, RELA, TNF, TNFRSF1A, VCAM1 |
| hsa05169 | Epstein-Barr virus infection | 18 | −14.82 | AKT1, BCL2, CASP3, CASP9, CDKN1A, HSPB1, ICAM1, IFNG, IKBKB, IL6, IL10, CXCL10, MYC, MAPK8, RELA, STAT1, TNF, TP53 |
| hsa04926 | Relaxin signaling pathway | 14 | −14.61 | AKT1, COL3A1, EGFR, FOS, MMP1, MMP2, MMP9, NOS2, NOS3, MAPK1, MAPK8, RELA, TGFB1, VEGFA |
| ko04210 | Apoptosis | 14 | −14.53 | PARP1, AKT1, BCL2, CASP3, CASP9, CTSD, FOS, IKBKB, MAPK1, MAPK8, RELA, TNF, TNFRSF1A, TP53 |
| ko05202 | Transcriptional misregulation in cancer | 14 | −12.96 | CDKN1A, IGFBP3, IL6, CXCL8, MMP3, MMP9, MPO, MYC, PLAT, PLAU, PPARG, RELA, RXRA, TP53 |
| ko04370 | VEGF signaling pathway | 8 | −9.30 | AKT1, CASP9, HSPB1, NOS3, PLA2G4A, MAPK1, PTGS2, VEGFA |
| hsa05216 | Thyroid cancer | 7 | −8.99 | CDKN1A, CTNNB1, MYC, PPARG, MAPK1, RXRA, TP53 |
| ko05220 | Chronic myeloid leukemia | 8 | −8.66 | AKT1, CDKN1A, IKBKB, MYC, MAPK1, RELA, TGFB1, TP53 |
| hsa04610 | Complement and coagulation cascades | 7 | −6.49 | F3, F7, CXCL10, SERPINE1, PLAT, PLAU, THBD |
| ko04670 | Leukocyte transendothelial migration | 7 | −5.84 | F3, F7, CXCL10, SERPINE1, PLAT, PLAU, THBD |
| ko05330 | Allograft rejection | 5 | −5.79 | CD40LG, IFNG, IL4, IL10, TNF |
| hsa04726 | Serotonergic synapse | 7 | −5.73 | ALOX5, APP, CASP3, PLA2G4A, MAPK1, PTGS1, PTGS2 |
| hsa04015 | Rap1 signaling pathway | 8 | −4.92 | AKT1, CTNNB1, EGF, EGFR, IL6, INSR, MAPK1, VEGFA |
| hsa04923 | Regulation of lipolysis in adipocytes | 5 | −4.92 | ADRB2, AKT1, INSR, PTGS1, PTGS2 |